TNFRSF14 and Hepatitis: To assess whether the activation status of DCs was altered in the absence of CD160, we measured the levels of multiple ligands on DCs, including CD1d, CD40, CD80, CD95, PD-L1, and HVEM, during α-GalCer-induced hepatitis.